Steven D Ertel Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven D Ertel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven D Ertel. Steven D Ertel is EVP & Chief Operating Officer in ACCELERON PHARMA INC ($XLRN) and SVP & Chief Business Officer in ACCELERON PHARMA INC ($XLRN).
Steven D Ertel in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steven D Ertel: EVP & Chief Operating Officer, SVP & Chief Business Officer
Holdings: 136,977 shares
Current Value: $3,251,834
Latest Transaction: Mar 14 2017
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven D Ertel in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | A | 30.17 | 47,300 | 1,427,041 | 47,300 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Grant | A | 0.00 | 7,900 | 0 | 136,977 | 144.9 K to 137 K (-5.45 %) |
| Jan 06 2017 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 27.61 | 1,900 | 52,459 | 129,077 | 131 K to 129.1 K (-1.45 %) |
| Jan 06 2017 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 26.92 | 600 | 16,152 | 130,977 | 131.6 K to 131 K (-0.46 %) |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 4,421 | 23,343 | 1,883 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 4,421 | 23,343 | 131,577 | 127.2 K to 131.6 K (+3.48 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 3,966 | 20,940 | 6,304 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 18,095 | 95,542 | 10,270 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 10,209 | 39,611 | 0 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 34.13 | 500 | 17,065 | 127,156 | 127.7 K to 127.2 K (-0.39 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 32.89 | 3,466 | 113,997 | 127,656 | 131.1 K to 127.7 K (-2.64 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 3,966 | 20,940 | 131,122 | 127.2 K to 131.1 K (+3.12 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 34.77 | 28,304 | 984,130 | 127,156 | 155.5 K to 127.2 K (-18.21 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 18,095 | 95,542 | 155,460 | 137.4 K to 155.5 K (+13.17 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 10,209 | 39,611 | 137,365 | 127.2 K to 137.4 K (+8.03 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | A | 27.97 | 45,000 | 1,258,650 | 45,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Grant | A | 0.00 | 7,500 | 0 | 127,156 | 119.7 K to 127.2 K (+6.27 %) |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 13,484 | 52,318 | 10,209 | |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.08 | 2,344 | 11,908 | 0 | |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 7.12 | 12,500 | 89,000 | 12,500 | |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 3,942 | 20,814 | 28,365 | |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 32.00 | 32,270 | 1,032,640 | 127,156 | 159.4 K to 127.2 K (-20.24 %) |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 13,484 | 52,318 | 159,426 | 145.9 K to 159.4 K (+9.24 %) |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.08 | 2,344 | 11,908 | 145,942 | 143.6 K to 145.9 K (+1.63 %) |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 7.12 | 12,500 | 89,000 | 143,598 | 131.1 K to 143.6 K (+9.53 %) |
| Apr 08 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 3,942 | 20,814 | 131,098 | 127.2 K to 131.1 K (+3.10 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 2,000 | 10,560 | 32,307 | |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 33.61 | 2,000 | 67,220 | 119,656 | 121.7 K to 119.7 K (-1.64 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 2,000 | 10,560 | 121,656 | 119.7 K to 121.7 K (+1.67 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Grant | A | 0.00 | 62,000 | 0 | 119,656 | 57.7 K to 119.7 K (+107.53 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 2,000 | 10,560 | 34,307 | |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 30.46 | 2,000 | 60,920 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 2,000 | 10,560 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 1,193 | 6,299 | 36,307 | |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 807 | 3,131 | 23,693 | |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.38 | 2,000 | 62,760 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 1,193 | 6,299 | 59,656 | 58.5 K to 59.7 K (+2.04 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 807 | 3,131 | 58,463 | 57.7 K to 58.5 K (+1.40 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 24,500 | |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.11 | 2,000 | 62,220 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 26,500 | |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.59 | 1,285 | 40,593 | 57,656 | 58.9 K to 57.7 K (-2.18 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.32 | 715 | 22,394 | 58,941 | 59.7 K to 58.9 K (-1.20 %) |
| May 18 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| May 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 28,500 | |
| May 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 5,000 | 19,400 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 33,500 | |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 33.58 | 2,000 | 67,160 | 52,656 | 54.7 K to 52.7 K (-3.66 %) |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 54,656 | 52.7 K to 54.7 K (+3.80 %) |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | A | 41.01 | 30,000 | 1,230,300 | 30,000 | |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.08 | 3,906 | 19,842 | 2,344 | |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 1.80 | 1,094 | 1,969 | 0 | |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 42.05 | 400 | 16,820 | 52,656 | 53.1 K to 52.7 K (-0.75 %) |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 41.28 | 2,043 | 84,335 | 53,056 | 55.1 K to 53.1 K (-3.71 %) |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 40.54 | 2,557 | 103,661 | 55,099 | 57.7 K to 55.1 K (-4.43 %) |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.08 | 3,906 | 19,842 | 57,656 | 53.8 K to 57.7 K (+7.27 %) |
| Mar 06 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 1.80 | 1,094 | 1,969 | 53,750 | 52.7 K to 53.8 K (+2.08 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 5,000 | 9,000 | 1,094 | |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.95 | 300 | 11,985 | 52,656 | 53 K to 52.7 K (-0.57 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.03 | 1,900 | 74,157 | 52,956 | 54.9 K to 53 K (-3.46 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 38.33 | 2,800 | 107,324 | 54,856 | 57.7 K to 54.9 K (-4.86 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 5,000 | 9,000 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 35,500 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 41.05 | 200 | 8,210 | 52,656 | 52.9 K to 52.7 K (-0.38 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 40.53 | 1,800 | 72,954 | 52,856 | 54.7 K to 52.9 K (-3.29 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 2,000 | 7,760 | 54,656 | 52.7 K to 54.7 K (+3.80 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 5,000 | 9,000 | 6,094 | |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.36 | 700 | 27,552 | 52,656 | 53.4 K to 52.7 K (-1.31 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 38.32 | 4,300 | 164,776 | 53,356 | 57.7 K to 53.4 K (-7.46 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 5,000 | 9,000 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 2,500 | 12,700 | 6,250 | |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 2,969 | 5,344 | 11,094 | |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.92 | 2,031 | 1,869 | 0 | |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 37.41 | 700 | 26,187 | 52,656 | 53.4 K to 52.7 K (-1.31 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.16 | 600 | 21,696 | 53,356 | 54 K to 53.4 K (-1.11 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.89 | 1,200 | 41,868 | 53,956 | 55.2 K to 54 K (-2.18 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 2,500 | 12,700 | 55,156 | 52.7 K to 55.2 K (+4.75 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 37.27 | 1,300 | 48,451 | 52,656 | 54 K to 52.7 K (-2.41 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.24 | 1,100 | 39,864 | 53,956 | 55.1 K to 54 K (-2.00 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.97 | 2,600 | 90,922 | 55,056 | 57.7 K to 55.1 K (-4.51 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 2,969 | 5,344 | 57,656 | 54.7 K to 57.7 K (+5.43 %) |
| Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.92 | 2,031 | 1,869 | 54,687 | 52.7 K to 54.7 K (+3.86 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 5,000 | 25,400 | 8,750 | |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.92 | 313 | 288 | 2,031 | |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.92 | 4,687 | 4,312 | 0 | |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 33.60 | 2,964 | 99,590 | 52,656 | 55.6 K to 52.7 K (-5.33 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 32.45 | 2,036 | 66,068 | 55,620 | 57.7 K to 55.6 K (-3.53 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 5,000 | 25,400 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 33.62 | 2,935 | 98,675 | 52,656 | 55.6 K to 52.7 K (-5.28 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 32.48 | 2,065 | 67,071 | 55,591 | 57.7 K to 55.6 K (-3.58 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.92 | 313 | 288 | 57,656 | 57.3 K to 57.7 K (+0.55 %) |
| Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.92 | 4,687 | 4,312 | 57,343 | 52.7 K to 57.3 K (+8.90 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 5,000 | 25,400 | 13,750 | |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.92 | 3,125 | 2,875 | 4,687 | |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 1,875 | 750 | 0 | |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 30.28 | 900 | 27,252 | 52,656 | 53.6 K to 52.7 K (-1.68 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.53 | 4,100 | 121,073 | 53,556 | 57.7 K to 53.6 K (-7.11 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 5,000 | 25,400 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 30.27 | 800 | 24,216 | 52,656 | 53.5 K to 52.7 K (-1.50 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.53 | 4,200 | 124,026 | 53,456 | 57.7 K to 53.5 K (-7.28 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.92 | 3,125 | 2,875 | 57,656 | 54.5 K to 57.7 K (+5.73 %) |
| Oct 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 1,875 | 750 | 54,531 | 52.7 K to 54.5 K (+3.56 %) |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 1,875 | |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 18,750 | |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 26.43 | 2,500 | 66,075 | 52,656 | 55.2 K to 52.7 K (-4.53 %) |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 55,156 | 52.7 K to 55.2 K (+4.75 %) |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 26.44 | 7,500 | 198,300 | 52,656 | 60.2 K to 52.7 K (-12.47 %) |
| Sep 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 60,156 | 52.7 K to 60.2 K (+14.24 %) |
| Aug 26 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 9,000 | 34,920 | 37,500 | |
| Aug 26 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 9,000 | 34,920 | 52,656 | 43.7 K to 52.7 K (+20.62 %) |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 26,250 | |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 4,375 | |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 30.37 | 100 | 3,037 | 43,656 | 43.8 K to 43.7 K (-0.23 %) |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.77 | 7,400 | 220,298 | 43,756 | 51.2 K to 43.8 K (-14.47 %) |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 51,156 | 43.7 K to 51.2 K (+17.18 %) |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.78 | 2,500 | 74,450 | 43,656 | 46.2 K to 43.7 K (-5.42 %) |
| Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 46,156 | 43.7 K to 46.2 K (+5.73 %) |
| Aug 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 8,000 | 31,040 | 46,500 | |
| Aug 01 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 8,000 | 31,040 | 43,656 | 35.7 K to 43.7 K (+22.44 %) |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 6,875 | |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 33,750 | |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.10 | 2,500 | 85,250 | 35,656 | 38.2 K to 35.7 K (-6.55 %) |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 38,156 | 35.7 K to 38.2 K (+7.01 %) |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.09 | 7,500 | 255,675 | 35,656 | 43.2 K to 35.7 K (-17.38 %) |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 43,156 | 35.7 K to 43.2 K (+21.03 %) |
| Jun 19 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 8,000 | 31,040 | 54,500 | |
| Jun 19 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 8,000 | 31,040 | 35,656 | 27.7 K to 35.7 K (+28.93 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 9,375 | |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 41,250 | |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | S | 29.73 | 2,500 | 74,325 | 27,656 | 25.2 K to 27.7 K (+9.94 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 30,156 | 27.7 K to 30.2 K (+9.04 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 30.04 | 200 | 6,008 | 27,656 | 27.9 K to 27.7 K (-0.72 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 29.71 | 7,300 | 216,883 | 27,856 | 35.2 K to 27.9 K (-20.76 %) |
| Jun 04 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 35,156 | 27.7 K to 35.2 K (+27.12 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 7,500 | 38,100 | 48,750 | |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 11,875 | |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 32.19 | 391 | 12,586 | 27,656 | 28 K to 27.7 K (-1.39 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 31.48 | 7,109 | 223,791 | 28,047 | 35.2 K to 28 K (-20.22 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 7,500 | 38,100 | 35,156 | 27.7 K to 35.2 K (+27.12 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 32.35 | 100 | 3,235 | 27,656 | 27.8 K to 27.7 K (-0.36 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 31.49 | 2,400 | 75,576 | 27,756 | 30.2 K to 27.8 K (-7.96 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 30,156 | 27.7 K to 30.2 K (+9.04 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.40 | 2,500 | 1,000 | 14,375 | |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.17 | 700 | 25,319 | 27,656 | 28.4 K to 27.7 K (-2.47 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 35.75 | 1,800 | 64,350 | 28,356 | 30.2 K to 28.4 K (-5.97 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.40 | 2,500 | 1,000 | 30,156 | 27.7 K to 30.2 K (+9.04 %) |
| Dec 09 2013 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | A | 24.11 | 29,000 | 699,190 | 29,000 |
Page: 1